Targeted Anticytokine Therapy in Patients With Chronic Heart FailureDouglas L. Mann, Thomas R. Fleming, Henry Krum et al.|Circulation|2004Cited by 1.2k
Myocardial Viability and Survival in Ischemic Left Ventricular DysfunctionRobert O. Bonow, Julio A. Panza, Gerald Maurer et al.|New England Journal of Medicine|2011Cited by 877
Cardiac S100A1 Protein Levels Determine Contractile Performance and Propensity Toward Heart Failure After Myocardial InfarctionPatrick Most, Walter J. Koch, Hanna Seifert et al.|Circulation|2006Cited by 145
Bcl-2–associated athanogene 3 protects the heart from ischemia/reperfusion injuryFeifei Su, Arthur M. Feldman|JCI Insight|2016Cited by 48
Arginine Vasopressin Enhances Cell Survival via a G Protein–Coupled Receptor Kinase 2/β-Arrestin1/Extracellular-Regulated Kinase 1/2–Dependent Pathway in H9c2 CellsWeizhong Zhu, Arthur M. Feldman|Molecular Pharmacology|2013Cited by 37